| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | WO2000071561A9 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 06/27/2002 | US20020083494 Genes regulating circadian clock function and photoperiodism |
| 06/27/2002 | US20020083492 Basidiomycete peroxidase gene-transferred plant and a method for decomposing and removing hazardous chemicals using the same |
| 06/27/2002 | US20020083489 DNA molecules and polypeptides of pseudomonas syringae Hrp pathogenicity island and their uses |
| 06/27/2002 | US20020083486 Chimeric plant promoters and plants containing the same |
| 06/27/2002 | US20020083481 Vectors and methods for the mutagenesis of mammalian genes |
| 06/27/2002 | US20020083479 Insertion of nucleotide sequences into genome of germ cells; obtain gonads, incubate with transfection mixture, allow insertion, monitor cells for preferential marker |
| 06/27/2002 | US20020082623 Vitro repair of bone and/or cartilage defects |
| 06/27/2002 | US20020082416 Method for obtaining DNA from fish spermatogonium |
| 06/27/2002 | US20020082414 Membrane protein for use in controlling vasodilation |
| 06/27/2002 | US20020082413 PGC-1, a novel brown fat PPARgamma coactivator |
| 06/27/2002 | US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 06/27/2002 | US20020082392 Antibodies to cell-cycle regulatory proteins, and uses related thereto |
| 06/27/2002 | US20020082388 Polypeptide for use in the treatment, diagnosis and prevention of cancer, nervous system and developmental disorders |
| 06/27/2002 | US20020082385 Protein for use in dietetics and the treatment of diabebtes |
| 06/27/2002 | US20020082236 A double stranded nucleic acid molecules with a first strand comprises an RNA sequence which codes for a protein of interest linked downstream of a flanking sequence and a translation initiation site inserted upstream of the RNA |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082228 Specific oligonucleotides (8-50 nucleobses) hybridize with nucleic acids encoding BH3 Interacting domain Death agonist |
| 06/27/2002 | US20020082217 Synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes |
| 06/27/2002 | US20020082211 Human presenilin variant |
| 06/27/2002 | US20020082205 Human FGF-23 gene and gene expression products |
| 06/27/2002 | US20020082190 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020081959 Method and apparatus for preparing a bone product |
| 06/27/2002 | US20020081739 Genetically engineering cells; obtain cell, obtain nucleotide sequences, adhere sequences to sheets, propel sheet into cells, recover transformed cells |
| 06/27/2002 | US20020081737 Generating biocompatible bead; obtain bead, incubate with probes, immobilize probe to bead, recover bead |
| 06/27/2002 | US20020081732 Electroprocessing in drug delivery and cell encapsulation |
| 06/27/2002 | US20020081731 Controlling metabolite generation in plants; generate plant culture, incubate with methylation inhibitor, culture cells, maintain cells |
| 06/27/2002 | US20020081730 HVD1 gene induced by salt stress |
| 06/27/2002 | US20020081728 Process for producing a vascularized bioartificial tissue and an experimental reactor for carrying out the process |
| 06/27/2002 | US20020081726 Microfabrication of membranes for the growth of cells |
| 06/27/2002 | US20020081725 Culturing pancreatic stem cells having a specified, intermediate stage of development |
| 06/27/2002 | US20020081724 Culture of stem cells; for use in human therapeutics |
| 06/27/2002 | US20020081723 Respiratory syncytial virus (RSV) fusion protein; treating or preventing RSV infection, as well as for diagnosis of RSV in analytes |
| 06/27/2002 | US20020081722 Nucleotide sequences coding preferential polypeptide for use in treatment and prevention of bacterial infection |
| 06/27/2002 | US20020081721 Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors |
| 06/27/2002 | US20020081720 Receptor activator of NF-kappaB |
| 06/27/2002 | US20020081709 Expression vector for use as tool in genetic engineering |
| 06/27/2002 | US20020081706 Negative strand rna viral vector having autonomous replication capability |
| 06/27/2002 | US20020081703 Reducing allegenic response heterologous proteins; obtain nucleotide sequences of heterologous protein, insert subtilisin sequences, transform cell, expression vector, recover protein, monitor human to protein |
| 06/27/2002 | US20020081695 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 06/27/2002 | US20020081690 Hybrid enzyme and use thereof |
| 06/27/2002 | US20020081683 Polypeptide for use in the diagnosis and treatment of psoriasis, infection, asthma and immune and respiratory disorders |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081664 Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081656 UDP-N-acetylglucosamine: Galactose-beta1,3-N-acetylgalactosamine-alpha-R / N-acetylglucosamine-beta1,3,-N-acetylgalactosamine-alpha-R (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2/4GnT |
| 06/27/2002 | US20020081653 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/27/2002 | US20020081649 Peptide for use in human therapeutics and diagnostics; for use as a antitumor agent |
| 06/27/2002 | US20020081648 Peptide for use in human thereapeutics and diagnostics |
| 06/27/2002 | US20020081634 Detecting preferential enzyme inhibitors; obtain sample containing protease, incubate with amyloid precursor protein, incubate with modulators, compare amount of amyloid precursor protein processing with control |
| 06/27/2002 | US20020081633 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 06/27/2002 | US20020081624 Detection of patients at risk for developing integrin antagonist/ agonist mediated disease states |
| 06/27/2002 | US20020081607 Four disulfide core domain-containing (FDCD) polynucleotides, polypeptides, and antibodies |
| 06/27/2002 | US20020081605 Method for detecting growth hormone variations in humans, the variations and their uses |
| 06/27/2002 | US20020081601 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 06/27/2002 | US20020081581 Compositions and methods for reverse transcription of nucleic acid molecules |
| 06/27/2002 | US20020081578 Nucleotide sequences coding preferential polypeptide for as anticarcinogenic agents |
| 06/27/2002 | US20020081576 Antibodies directed against binding-associated epitopes |
| 06/27/2002 | US20020081568 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds |
| 06/27/2002 | US20020081299 Hair cell disorders |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | US20020081286 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/27/2002 | US20020081285 Treatment for diabetes |
| 06/27/2002 | US20020081284 Manipulation of arterial-venous identity |
| 06/27/2002 | US20020081283 Immortalizing the hepatocytes by transforming the hepatocytes with a DNA construct comprising a removable DNA segment containing oncogene, growing immortalized hepatocytes, removing oncogene from immortalized hepatocytes |
| 06/27/2002 | US20020081282 Genetically engineered cell comprising DNA encoding a transmembrane LAG-3 protein (lymphocyte activting gene) on its surface resulting in the protection from graft rejection by a host's immune system |
| 06/27/2002 | US20020081279 In vitro manipulation of a plasmid-cloned chicken embryo lethal orphan (CELO) virus DNA, suitable for the production of vectors for gene therapy and as a vaccine against infectious diseases in human and animals, particularly birds |
| 06/27/2002 | CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2433027A1 Nucleic acid-associated proteins |
| 06/27/2002 | CA2432762A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 06/27/2002 | CA2432760A1 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2432157A1 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 06/27/2002 | CA2432036A1 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | CA2431994A1 Method for the production of polyfructans |
| 06/27/2002 | CA2431990A1 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | CA2431891A1 Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | CA2431884A1 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 06/27/2002 | CA2431446A1 High affinity antibodies |
| 06/27/2002 | CA2431139A1 Oxidoreductases |
| 06/27/2002 | CA2430973A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | CA2430918A1 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | CA2430754A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/27/2002 | CA2430475A1 Methods and cells for detecting modulators of rgs proteins |
| 06/27/2002 | CA2327581A1 Methods and compositions for the establishment of genetically altered cell-based library designed for monitoring transcriptional activity of compounds and molecules |
| 06/26/2002 | EP1217377A2 Process for the specific detection of tumour cells and their precursors in cervical smears through simultaneous measurement of at least two different molecular markers |
| 06/26/2002 | EP1217077A2 Novel bioluminescent assays and bacterial strains useful therein |
| 06/26/2002 | EP1217073A2 Transformed plants with improved tolerance to phosphomethylglycine family herbicides containing a gene encoding a mutated 5-enolpyruvylshikimate-3-phophate synthase |
| 06/26/2002 | EP1217071A1 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 06/26/2002 | EP1217067A2 Connective tissue growth factor-2 |
| 06/26/2002 | EP1217007A2 Serum paraoxonase |
| 06/26/2002 | EP1216710A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 06/26/2002 | EP1216302A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 06/26/2002 | EP1216300A1 Methods and compositions relating to sodium channel beta1a subunits |
| 06/26/2002 | EP1216297A2 Double transgenic animals as models for neurodegenerative disease |
| 06/26/2002 | EP1216234A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 06/26/2002 | EP1216055A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 06/26/2002 | EP1216049A2 Methods for treating muscular dystrophy with bone marrow cells |